Facebook不甘人后 将开拓医疗健康领域

2014-10-04 新浪科技 新浪科技

Facebook正计划构建一个在线“支持社区”,连接患有各种疾病的Facebook用户路透社今日援引3位知情人士的消息称,继谷歌和苹果公司之后,Facebook也将进军健康服务市场。知情人士称,Facebook正计划构建一个在线“支持社区”,连接患有各种疾病的Facebook用户。同时,Facebook的小团队还考虑开发一些“预防保健”类应用,帮助人们提高生活质量。这些知情人士称,最近几个月,Fa

Facebook正计划构建一个在线“支持社区”,连接患有各种疾病的Facebook用户
Facebook正计划构建一个在线“支持社区”,连接患有各种疾病的Facebook用户

路透社今日援引3位知情人士的消息称,继谷歌和苹果公司之后,Facebook也将进军健康服务市场。

知情人士称,Facebook正计划构建一个在线“支持社区”,连接患有各种疾病的Facebook用户。同时,Facebook的小团队还考虑开发一些“预防保健”类应用,帮助人们提高生活质量。

这些知情人士称,最近几个月,Facebook一直在与医疗行业的专家和企业家开会,计划组建一个研发部门来测试新健康应用。但到目前为止,该项目仍处于意见搜集阶段。

Facebook一直都对健康服务感兴趣,但并未采取积极的行动。最近,Facebook高管们似乎意识到健康服务或有助于提高用户参与度。

证据之一是,Facebook在2012年推出的“器官捐赠状态计划”取得了超预期的成功。Facebook开放器官捐赠状态页面当天,美国共有1.3万多名用户注册成为器官捐赠者,是平时的21倍。

同时,Facebook产品团队还注意到,糖尿病等慢性病患者会在Facebook上寻求建议。另外,包括PatientsLikeMe在内的患者网络的流行也表明,患者越来越愿意在网上与他人分享诊断和治疗疾病的经验。

除此之外,Facebook CEO马克·扎克伯格(Mark Zuckerberg)也可能更加关注健康事务。扎克伯格妻子普利希拉·陈(Priscilla Chan)是一位医生,两人最近曾向Ravenswood健康中心捐赠了500万美元。

有分析人士指出,Facebook进军保健服务市场将面临隐私方面的挑战。最近几年,Facebook已经因为隐私问题而备受指责。就在本周,Facebook还因操纵用户信息流而向用户致歉。

但是,针对健康服务可能引发的隐私问题,Facebook可能已经有了一些想法。其中一位知情人士称,Facebook正考虑悄悄推出第一款健康应用,且使用不同的名称(即不是“Facebook”)。因为调查结果显示,许多用户并不知道照片服务Instagram是Facebook旗下服务。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1741877, encodeId=ee961e41877c6, content=<a href='/topic/show?id=9cafe211d9' target=_blank style='color:#2F92EE;'>#Facebook#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7211, encryptionId=9cafe211d9, topicName=Facebook)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a934990833, createdName=wgsun, createdTime=Sun Jan 04 18:58:00 CST 2015, time=2015-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052464, encodeId=fc6720524647a, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Fri Aug 14 00:58:00 CST 2015, time=2015-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655707, encodeId=bfa41655e070a, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Thu Aug 13 10:58:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956629, encodeId=e52d1956629c8, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7210, encryptionId=7647e210ac, topicName=FAC)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Jul 04 04:58:00 CST 2015, time=2015-07-04, status=1, ipAttribution=)]
    2015-01-04 wgsun
  2. [GetPortalCommentsPageByObjectIdResponse(id=1741877, encodeId=ee961e41877c6, content=<a href='/topic/show?id=9cafe211d9' target=_blank style='color:#2F92EE;'>#Facebook#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7211, encryptionId=9cafe211d9, topicName=Facebook)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a934990833, createdName=wgsun, createdTime=Sun Jan 04 18:58:00 CST 2015, time=2015-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052464, encodeId=fc6720524647a, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Fri Aug 14 00:58:00 CST 2015, time=2015-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655707, encodeId=bfa41655e070a, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Thu Aug 13 10:58:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956629, encodeId=e52d1956629c8, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7210, encryptionId=7647e210ac, topicName=FAC)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Jul 04 04:58:00 CST 2015, time=2015-07-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1741877, encodeId=ee961e41877c6, content=<a href='/topic/show?id=9cafe211d9' target=_blank style='color:#2F92EE;'>#Facebook#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7211, encryptionId=9cafe211d9, topicName=Facebook)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a934990833, createdName=wgsun, createdTime=Sun Jan 04 18:58:00 CST 2015, time=2015-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052464, encodeId=fc6720524647a, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Fri Aug 14 00:58:00 CST 2015, time=2015-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655707, encodeId=bfa41655e070a, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Thu Aug 13 10:58:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956629, encodeId=e52d1956629c8, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7210, encryptionId=7647e210ac, topicName=FAC)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Jul 04 04:58:00 CST 2015, time=2015-07-04, status=1, ipAttribution=)]
    2015-08-13 shanyongle
  4. [GetPortalCommentsPageByObjectIdResponse(id=1741877, encodeId=ee961e41877c6, content=<a href='/topic/show?id=9cafe211d9' target=_blank style='color:#2F92EE;'>#Facebook#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7211, encryptionId=9cafe211d9, topicName=Facebook)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03a934990833, createdName=wgsun, createdTime=Sun Jan 04 18:58:00 CST 2015, time=2015-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2052464, encodeId=fc6720524647a, content=<a href='/topic/show?id=271f2e96486' target=_blank style='color:#2F92EE;'>#健康领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27964, encryptionId=271f2e96486, topicName=健康领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4b7363, createdName=pandamao2010, createdTime=Fri Aug 14 00:58:00 CST 2015, time=2015-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1655707, encodeId=bfa41655e070a, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1829, encryptionId=2a011829d7, topicName=ACE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=635024767990, createdName=shanyongle, createdTime=Thu Aug 13 10:58:00 CST 2015, time=2015-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956629, encodeId=e52d1956629c8, content=<a href='/topic/show?id=7647e210ac' target=_blank style='color:#2F92EE;'>#FAC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7210, encryptionId=7647e210ac, topicName=FAC)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B389FA68ECBF51BE2FE14093CF61F6AE/100, createdBy=eb8e2500096, createdName=夏天与十三菇凉, createdTime=Sat Jul 04 04:58:00 CST 2015, time=2015-07-04, status=1, ipAttribution=)]

相关资讯

Facebook收购Moves开发商,进军健康追踪领域

北京时间4月24日TechWeb报道,Facebook于周四宣布已经收购了芬兰创业公司ProtoGeo Oy,该公司是健康类移动追踪应用Moves的开发商,成立仅2年时间。 Facebook并未透露此次交易的具体金额,但是业界分析此次交易额度不会太大。此前,Facebook分别以20亿美元、190亿美元收购了虚拟现实技术开发商 Oculus VR和社交应用WhatsApp。 健康移动追踪类应用——